AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 187 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $217,311 | -86.4% | 7,717 | -77.7% | 0.00% | -100.0% |
| Q3 2021 | $1,594,000 | +316.2% | 34,531 | +380.6% | 0.00% | +200.0% |
| Q2 2021 | $383,000 | +7.3% | 7,185 | +33.3% | 0.00% | – |
| Q1 2019 | $357,000 | +43.4% | 5,392 | 0.0% | 0.00% | – |
| Q4 2018 | $249,000 | -74.0% | 5,392 | -56.5% | 0.00% | -100.0% |
| Q3 2018 | $957,000 | -11.3% | 12,409 | -3.1% | 0.00% | 0.0% |
| Q2 2018 | $1,079,000 | +57.1% | 12,811 | +8.9% | 0.00% | 0.0% |
| Q1 2017 | $687,000 | -86.6% | 11,764 | -90.5% | 0.00% | -85.7% |
| Q4 2016 | $5,145,000 | -26.9% | 123,303 | -7.5% | 0.01% | -36.4% |
| Q3 2016 | $7,041,000 | +376.1% | 133,306 | +277.6% | 0.01% | +266.7% |
| Q2 2016 | $1,479,000 | +11.4% | 35,308 | +72.6% | 0.00% | +50.0% |
| Q4 2015 | $1,328,000 | -20.0% | 20,454 | -13.1% | 0.00% | -33.3% |
| Q3 2015 | $1,661,000 | -67.0% | 23,527 | -48.0% | 0.00% | -70.0% |
| Q2 2015 | $5,030,000 | +40.0% | 45,261 | +18.8% | 0.01% | +25.0% |
| Q1 2015 | $3,592,000 | +1085.5% | 38,100 | +1311.1% | 0.01% | +700.0% |
| Q4 2014 | $303,000 | -64.7% | 2,700 | -80.7% | 0.00% | -50.0% |
| Q3 2014 | $859,000 | – | 14,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |